TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Investor Investigation Concerning Possible Wrongdoing Announced

  • If you purchased shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Alnylam Pharmaceuticals
Security
NASDAQ: ALNY

Summary

July 20, 2015 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Alnylam Pharmaceuticals.

The investigation by a law firm concerns whether certain Alnylam Pharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Alnylam Pharmaceuticals, Inc. reported that its annual Total Revenue rose from $47.17 million in 2013 to $50.56 million in 2014 while its respective Net Loss increased from $89.22 million to $360.39 million.

Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) grew from $53.71 per share in August 2014 to as high as $138.73 per share in June 2015.

Start Monitoring Your Investments